Search Results
Mar 12, 2026, 05:59 ET Praana Group treibt strategische Expansion mit der Ernennung von Darpan Parikh voran
Multi-Chem-Geschäfts, wodurch die Fähigkeiten des Unternehmens im Bereich Spezialchemikalien auf den Energie- und Industriemärkten erweitert werden.(iii) mit Arkema für den geplanten Erwerb der Produktionsanlage in Vlissingen in den Niederlanden und der damit verbundenen Geschäftsbereiche für Kunststoffadditive,
More news about: Praana Group
Mar 12, 2026, 05:00 ET Earendil Labs and WuXi Biologics Enter Strategic Collaboration to Accelerate Development and Manufacturing of Bispecific/Multispecific Antibodies and ADCs
development and manufacturing solutions. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing.WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously
More news about: Earendil Labs
Mar 12, 2026, 04:25 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
understanding of the effects of its drug candidate on patients with Osteogenesis Imperfecta ("OI"). The Company's failures were revealed by the Phase III ORBIT study in which it failed to achieve a statistically significant reduction in annualized fracture rate ("AFR"). Based on these facts, the Company's
More news about: The Schall Law Firm
Mar 12, 2026, 04:18 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
statements to the market. Ultragenyx gave created falsely optimistic beliefs for its investors regarding the performance of its drug candidate in its Phase III trial. The Company failed to achieve statistically significant endpoints despite its optimistic communications. Based on these facts, Ultragenyx's public
More news about: DJS Law Group LLP
Mar 12, 2026, 01:29 ET Haier Biomedical проводит Европейский партнерский саммит в Риме, продвигая стратегию «В Европе, для Европы»
продукции.От морозильных камер к комплексным решениямСреди представленных новинок особое внимание привлекла система плазмафереза Plasma Apheresis XJ-III. Система прошла сертификацию согласно регламенту ЕС MDR, что знаменует собой важную веху в обеспечении соответствия строгим европейским нормативным
More news about: Haier Biomedical
Mar 12, 2026, 00:42 ET Haier Biomedical realiza a Cúpula Europeia de Parceiros em Roma e avança com a estratégia "Na Europa, para a Europa"
produtos.Expandindo de freezers para soluções completasEntre os produtos recentemente apresentados, o Sistema de Aférese de Plasma XJ-III chamou atenção especial. O sistema obteve a certificação EU MDR, o que representa um marco significativo no atendimento aos rigorosos requisitos regulatórios
More news about: Haier Biomedical
Mar 12, 2026, 00:31 ET Haier Biomedical celebra la Cumbre Europea de Colaboradores en Roma y promueve la estrategia "En Europa, para Europa"
refrigeración hacia soluciones integralesEntre los productos recién presentados, llamó la atención especialmente el Plasma Apheresis System XJ-III. El sistema ha obtenido la certificación EU MDR, lo que representa un importante hito en el cumplimiento de los rigurosos requisitos normativos europeos
More news about: Haier Biomedical
Mar 12, 2026, 00:01 ET Hyundai is the Most Awarded Automaker on the 2026 Best Cars for Families List by U.S. News and World Report
availability is not guaranteed.iiiThe 2026 IONIQ 9 is assembled in Georgia from
More news about: Hyundai Motor America
Mar 11, 2026, 22:51 ET Haier Biomedical organizuje v Ríme summit európskych partnerov a rozvíja stratégiu „v Európe, pre Európu"
portfólio.Od mrazničiek po kompletné riešeniaMedzi novo predstavenými produktmi upútal osobitnú pozornosť systém plazmatickej aferézy XJ-III. Systém získal certifikáciu EÚ MDR, čo predstavuje významný míľnik v splnení prísnych európskych regulačných požiadaviek a posilňuje pozíciu spoločnosti
More news about: Haier Biomedical
Mar 11, 2026, 21:54 ET CWH Stockholder Alert: Robbins LLP Remind Investors of the Securities Class Action Lawsuit Against Camping World Holdings, Inc.
optimize profit using "data analytics;" (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; and (iv)
More news about: Robbins LLP
Mar 11, 2026, 20:05 ET Stoneridge Reports Fourth Quarter and Full-Year 2025 Results
respect to, among other things, our (i) future product and facility expansion, (ii) strategic focus following the sale of the Control Devices segment, (iii) acquisition strategy, (iv) investments and new product development, (v) growth opportunities related to awarded business, and (vi) operational expectations.
More news about: Stoneridge, Inc.
Mar 11, 2026, 17:31 ET Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
bipolar depression are expected in the second quarter of 2026.In January 2026, JP Morgan Healthcare Conference reported that the Phase III X-CEED study evaluating azetukalner in patients with bipolar depression I or II is underway.What is Bipolar Depression?Bipolar
More news about: DelveInsight Business Research, LLP
Mar 11, 2026, 17:22 ET Haier Biomedical accueille le sommet des partenaires européens à Rome et poursuit sa stratégie « En Europe, pour l'Europe »
produits.Extension des congélateurs aux solutions complètesParmi les produits nouvellement introduits, le système d'aphérèse du plasma XJ-III a particulièrement retenu l'attention. Le système a obtenu la certification du règlement relatif aux dispositifs médicaux (MDR) de l'UE, ce qui représente
More news about: Haier Biomedical
Mar 11, 2026, 16:15 ET KLX ENERGY SERVICES HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
ratio covenant, (ii) a temporary holiday to exclude capital lease obligations from the leverage ratio calculation for certain testing periods, and (iii) clarifying that proceeds from our at-the-market offering program may be applied as an equity cure. In connection with the entry into the First Amendment
More news about: KLX Energy Services Holdings, Inc.
Mar 11, 2026, 16:05 ET Petco Reports Fourth Quarter and Full Year 2025 Results
from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments;
More news about: Petco - Investor Relations
Mar 11, 2026, 16:02 ET Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026
on a strategy that accelerated inorganic growth, which led to the successful completion of the Company's acquisition of Nu Aire," said Thomas D. Hull III, Kewaunee's President and Chief Executive Officer. "Since then, our teams have worked diligently to integrate Nu Aire into the Kewaunee family and position
More news about: Kewaunee Scientific Corporation
Mar 11, 2026, 15:45 ET Greenberg Traurig Continues Expansion of Corporate Practice with Private Equity Attorney William R. 'Bill' Halaby III
Corporate Practice with the addition of William R. "Bill" Halaby III as a shareholder in the firm's
More news about: Greenberg Traurig, LLP
Mar 11, 2026, 13:06 ET DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
health, substance use disorders, and digital health, who brings deep experience in health care and opioid addition.Oliver Benton Curtis III – Mr. Curtis is a former federal prosecutor and accomplished trial lawyer who currently advises on regulatory enforcement, internal investigations,
More news about: DOMA Perpetual
Mar 11, 2026, 12:19 ET Haier Biomedical organiza la Cumbre Europea de Socios en Roma
expansión.Expansión de congeladores a soluciones completasEntre los nuevos productos presentados, el Sistema de Aféresis de Plasma XJ-III atrajo especial atención. El sistema ha obtenido la certificación MDR de la UE, lo que marca un hito importante en el cumplimiento de los estrictos requisitos
More news about: Haier Biomedical
Mar 11, 2026, 12:15 ET Haier Biomedical organizuje europejski szczyt partnerów w Rzymie i promuje strategię „W Europie, dla Europy"
zamrażarek po kompleksowe rozwiązaniaWśród nowo wprowadzonych produktów szczególną uwagę zwrócił system do aferezy osocza XJ-III. System uzyskał certyfikat MDR UE, co stanowi znaczący kamień milowy w zakresie zapewnienia zgodności z rygorystycznymi wymogami regulacyjnymi w Europie
More news about: Haier Biomedical
Mar 11, 2026, 12:02 ET Haier Biomedical veranstaltet europäischen Partner-Gipfel in Rom und treibt Strategie „In Europa, für Europa" voran
wird.Erweiterung von Gefrierschränken zu Komplettlösungen Unter den neu vorgestellten Produkten zog das Plasma-Apherese-System XJ-III besondere Aufmerksamkeit auf sich. Das System hat die EU-MDR-Zertifizierung erhalten, was einen bedeutenden Meilenstein bei der Erfüllung der strengen
More news about: Haier Biomedical
Mar 11, 2026, 11:45 ET REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
multimedia:https://www.prnewswire.com/news-releases/regenxbio-reports-new-positive-interim-data-from-phase-iii-affinity-duchenne-trial-of-rgx-202-302711193.htmlSOURCE
More news about: REGENXBIO Inc.
Mar 11, 2026, 10:17 ET Olympus Launches Next-Generation Surgical Imaging Platform in U.S.
ELITE™ III Platform Was Developed by the SONY Olympus Medical Joint VentureWESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ -- Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical
More news about: Olympus Corporation of the Americas
Mar 11, 2026, 09:42 ET PLUG SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.On October 7, 2025, Plug Power issued
More news about: Faruqi & Faruqi, LLP
Mar 11, 2026, 09:25 ET LAKE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Lakeland Industries (LAKE) Investors of Securities Class Action Deadline on April 27, 2026
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Faruqi & Faruqi, LLP